Showing results (441-450 of 2,397) with videos related to
Sort By:
Pageof 240
Translational Lung Cancer Research|December 13, 2024
Characterization of the BH1406 non-small cell lung cancer (NSCLC) cell line carrying an activating SOS1 mutationGerhard Hamilton, Sandra Stickler, Mikhail Ermakov, et al.Translational Lung Cancer Research|December 13, 2024
EGFR-V834L combined with L858R mutation reduced afatinib sensitivity and associated to early recurrence in lung cancerNanao Terada, Hayato Koba, Shigeki Nanjo, et al.Translational Lung Cancer Research|December 13, 2024
The potential high-risk population for lung cancer screening: determination of initial screening age and heterogeneity in histology and sexKeyi Chen, Yanze Yin, Chao Wang, et al.Translational Lung Cancer Research|December 13, 2024
Construction of a risk prediction model for isolated pulmonary nodules 5-15 mm in diameterSiting Xie, Xingguang Luo, Yuxin Guo, et al.Translational Lung Cancer Research|February 17, 2025
The utility and feasibility of three-dimensional reconstruction in surgical planning for multiple pulmonary nodules: a prospective self-controlled studyZhifei Li, Runze Li, Lei Liu, et al.Translational Lung Cancer Research|February 17, 2025
Recurrence as a small cell lung cancer transformation in a resected stage IIIA EGFR-mutated non-small cell lung cancer treated with adjuvant osimertinib: a case reportJulie Lasvergnas, Isabelle Monnet, Jean-Bernard Auliac, et al.Translational Lung Cancer Research|February 17, 2025
Efficacy and safety of first-line immunotherapy-based regimens for patients with extensive-stage small cell lung cancer: a systematic review and network meta-analysisWengang Zhang, Wencheng Zhao, Xinyu Zhang, et al.Translational Lung Cancer Research|February 17, 2025
Patient-reported outcomes in the early postoperative period following resection of unilateral multiple pulmonary nodules: implications for surgical decision-makingQian Hong, Hang Yi, Yan Wang, et al.Translational Lung Cancer Research|February 17, 2025
Anlotinib enhances the anti-tumor activity of osimertinib in patients with non-small cell lung cancer by reversing drug resistanceXin Hua, Xiaodi Wu, Liting Lv, et al.Translational Lung Cancer Research|January 20, 2025
Efficacy and safety of consolidative thoracic radiotherapy after first-line chemoimmunotherapy in patients with extensive-stage small-cell lung cancer: a retrospective cohort studyLin Zheng, Yang Yang, Fan Bu, et al.Pageof 240